General Information
Drug ID
DR00053
Drug Name
Sodium taurocholate
Synonyms
Sodium taurocholate (rectal gel, diabetes/ obesity)
Drug Type
Small molecular drug
Indication Type 2 diabetes [ICD11: 5A11] Preclinical [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=23666345"></iframe>
3D MOL 2D MOL
Formula
C26H44NNaO7S
Canonical SMILES
CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C.[Na+]
InChI
InChI=1S/C26H45NO7S.Na/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29;/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34);/q;+1/p-1/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-;/m1./s1
InChIKey
JAJWGJBVLPIOOH-IZYKLYLVSA-M
CAS Number
CAS 145-42-6
Pharmaceutical Properties Molecular Weight 537.688 Topological Polar Surface Area 155
Heavy Atom Count 36 Rotatable Bond Count 7
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 7
PubChem CID
23666345
ChEBI ID
CHEBI:36276
TTD Drug ID
D03BZN
DT(s) Transporting This Drug ABCA8 Transporter Info ATP-binding cassette sub-family A member 8 Substrate [2]
ASBT Transporter Info Apical sodium-dependent bile acid transporter Substrate [3]
BSEP Transporter Info Bile salt export pump Substrate [4]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
MRP3 Transporter Info Multidrug resistance-associated protein 3 Substrate [5]
NTCP Transporter Info Sodium/taurocholate cotransporting polypeptide Substrate [6]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [7]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [8]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [9]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [10]
OSTbeta Transporter Info Organic solute transporter subunit beta Substrate [11]
Drug-Transporter Activity Data
Drug-Transporter Activity Data ABCA8 Transporter Info Km = 10.3 microM Xenopus laevis oocytes-ABCA8 [2]
ASBT Transporter Info Km = 9.4 microM Human embryonic kidney cells (HEK293)-ASBT [3]
ASBT Transporter Info Km = 13.3 microM Monkey kidney fibroblast-like cell (COS)1-ASBT [12]
ASBT Transporter Info Km = 16 microM Monkey kidney fibroblast-like cell (COS)7-ASBT [13]
BSEP Transporter Info Km = 4.64 microM Human embryonic kidney cells (HEK293)-BSEP [4]
BSEP Transporter Info Km = 15 microM Spodoptera frugiperda (Sf9) cells-BSEP [14]
MRP3 Transporter Info Km = 30 microM Human embryonic kidney cells (HEK293)-MRP3 [5]
NTCP Transporter Info Km = 7.5 microM Human cervical cancer cell line (Hela)-NTCP [15]
NTCP Transporter Info Km = 7.9 microM Human cervical cancer cell line (Hela)-NTCP [16]
NTCP Transporter Info Km = 2.1 microM Human embryonic kidney cells (HEK293)-NTCP [6]
OATP1A2 Transporter Info Km = 60 microM Oocytes-OATP1A2 [7]
OATP1B3 Transporter Info Km = 5.8 microM Oocytes-OATP1B3 [9]
OATP2B1 Transporter Info Km = 71.8 microM Human embryonic kidney cells (HEK293)-OATP2B1 [10]
References
1 Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.Acta Pharmaceutica Sinica B Volume 5, Issue 2, March 2015, Pages 151-157.
2 Functional analysis of ABCA8, a new drug transporter. Biochem Biophys Res Commun. 2002 Oct 18;298(1):41-5.
3 Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry. 2002 Dec 17;41(50):14916-24.
4 Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther. 2005 Aug;314(2):876-82.
5 Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry. 2003 Aug 26;42(33):9989-10000.
6 Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Ther. 2007 Jun;321(3):1170-8.
7 Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995 Oct;109(4):1274-82.
8 Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. Int J Mol Sci. 2018 Mar 14;19(3). pii: E855.
9 LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.
10 Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther. 2004 Feb;308(2):438-45.
11 OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology. 2005 Dec;42(6):1270-9.
12 Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1 Pt 1):G157-69.
13 Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2039-45.
14 Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors. Drug Metab Dispos. 2009 Sep;37(9):1878-86.
15 Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem. 2004 Feb 20;279(8):7213-22.
16 Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther. 1999 Dec;291(3):1204-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.